Liver, Gallbladder, and Exocrine Pancreas Flashcards
1
Q
Jaundice
A
- Yellow discoloration of skin, and tissues caused by hyperbilirubinemia
- Earliest sign is scleral icterus
- Arises with disturbances in bilirubin metabolism
2
Q
Gilbert syndrome
A
- Congenital hyperbilirubinemia
- Extremely common
- Characterized by modest elevation of serum unconjugated bilirubin; the liver is otherwise unimpaired.
- Caused by combination of decreased bilirubin uptake by liver cells and reduce activity of glucuronyl transferase
3
Q
Crigler-Najjar syndrome
A
- Congenital hyperbilirubinemia
- Severe familial disorder characterized by unconjugated hyperbilirubinemia
- Caused by deficiency of glucuronyl transferase
4
Q
Dubin-Johnson syndrome
A
- Congenital hyperbilirubinemia
- Autosomal recessive form of conjugated hyperbilirubinemia
- Characterized by defective bilirubin transport
- Striking brown-to-black discoloration of the liver
5
Q
Acute viral hepatitis
A
- Inflammation of liver parenchyma
- Characterized by jaundice with dark urine, fever, malaise, and nausea
- Elevated serum aspartate and alanine aminotransferases
- Usually due to hepatitis virus, but may also be caused by EBV or CMV
- HAV: spread by fecal-oral transmission; parenteral infection does not occur. Does not cause a chronic carrier state
- HBV: transmitted via parenteral, sexual, and vertical routs; associated with a “ground-glass” appearance of hepatocytes; can result in a carrier state or in chronic liver disease; HBsAg, HBeAg, Anti-HBcAg, HBV DNA. Hepatocyte damage results from CD8+ T cells
- HCV: transmittes parenteral, frequent cause of transfusion-mediated hepatitis. 85% progresses to chronic hepatitis
- HDV: replicatively defective, requiring simultaneous infection with HBV (HBsAg is necessary for development of HDV visions); sexual or parenteral transmission; high in IV drug users
6
Q
Chronic hepatitis
A
- Inflammation of liver parenchyma that persist for more than 6 months
- May result from any of the viral hepatitides except HAV or HEV and also from liver damage induced by nonviral agents
- Risk of progression to cirrhosis
- Inflammation predominantly in portal tract
7
Q
Reye syndrome
A
- Acute disorder of young children characterized by encephalopathy, coma, and microvesicular fatty liver
- Associated with aspirin administration to children with acute viral infections
- Likely related to mitochondrial damage of hepatocytes
- Characterized by extensive accumulation of fat droplets within hepatocytes
- Present with hypoglycemia, elevated liver enzymes, and nausea with vomiting
8
Q
Alcoholic liver disease
A
- The most common form of liver disease in US
(1) Fatty change (steatosis) - most frequent morphological abnormality caused by alcohol and is reversible
(2) Alcohol hepatitis - characterized by fatty change, focal liver cell necrosis, infiltrates of neutrophils, and presence of Mallory bodies (eosinophilic cytoplasmic clumps in hepatocytes). Often associated with irreversible fibrosis that characteristically surrounds central veins and has been referred to as perivenular fibrosis
(3) Alcoholic cirrhosis
9
Q
Cirrhosis
A
- End-stage liver damage
- Characterized by generalized disorganization of hepatic architecture with scarring and nodule formation.
- Liver cell damage, regenerative activity, and generalized fibrosis resulting in a nodular pattern
- In all forms, there is an increased incidence of hepatocellular carcinoma
- Stellate cell: fibrosis is mediated by TGF-beta from stellate cells
- Etiology: prolonged alcohol intake (60-70%), drugs, and chemical agents, viral hepatitis (10%), biliary obstruction, hemochromatosis, Wilson disease and other inborn errors of metabolism, heart failure with long-standing chronic passive congestion of the liver
10
Q
Alcoholic cirrhosis
A
- Prototype for all forms of cirrhosis
- Present with jaundice, hypoalbuminemia, coagulation factor deficiencies, hyperestrinism,
- Consequences of intrahepatic scarring with increased portal venous pressure: esophageal varicose, rectal hemorrhoids, periumbilical venous collaterals, splenomegaly
- Changes: peripheral edema, ascites, hydrothorax, encephalopathy
11
Q
Postnecrotic cirrhosis
A
- Characterized by broad fibrous bands dividing the liver into large, irregular nodules
- Often a sequel of chronic active hepatitis; HBV and HCV are the most common viral causes
- Leads to hepatocellular carcinoma more often than other forms of cirrhosis
12
Q
Bilary cirrhosis
A
- Occur as primary, probably autoimmune, disorder and much more frequently as a secondary from due to biliary obstruction
(1) Primary biliary cirrhosis - most likely of autoimmune origin, antimitochondrial antibodies are characteristic. Present with severe obstructive jaundice, itching, and hypercholesterolemia
(2) Secondary biliary cirrhosis - caused by extrahepatic biliary obstruction
13
Q
Primary sclerosing cholangitis
A
- Associated with inflammatory bowel disease, especially ulcerative colitis
- Characteristically include inflammation, fibrosis (“onion skin fibrosis”), and stenosis of intrahepatic and extra hepatic bile ducts
14
Q
Hemochromatosis
A
- Excess body iron leading to deposition in tissues and organ damage
- Damage is mediated by generation of free radicals
(1) Primary - due to mutations in HFE gene on chromosome 6, most commonly C282Y, or mutation in transferrin receptor 2 (TfR2) - Presents in late adulthood - cirrhosis, secondary DM, increased skin pigmentation, bronze skin, cardiac arrhythmia and gonadal dysfunction
- Increased ferritin, serum iron and precent saturation, and decreased TIBC
(2) Secondary - most often associated with a combination of ineffective erythropoiesis and multiple transfusions
15
Q
Wilson disease
A
- Autosomal recessive disorder of copper metabolism - defect in ATP-mediated hepatocyte copper transport
- AR (mutation in ATP7B gene, chr.13)
- Impaired copper excretion into bile + failure to incorporate Cu into ceruloplasmin
- Characterized by decreased serum ceruloplasmin (copper-binding protein)
- Kayser-Fleischer ring - green ton brown deposits of Cu in the cornea
- Result in accumulation of copper in parenchymal cells of the liver and kidney and in the brain and cornea